-

STEMCELL Technologies Partners with Science World to Empower Girls Pursuing Science-related Careers

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce it will be the presenting partner of the Girls and STEAM Summit at Science World in Vancouver.

The Summit, which takes place on November 4, 2023, is a full-day event with workshops, hands-on activities, a keynote presentation, and sessions with experienced mentors who work in STEAM (science, technology, engineering, art and design, and math).

“Science is about so much more than what happens in the laboratory. It provides a lens that can instill a deep-seated curiosity in young minds and enrich every aspect of our lives,” said Sharon Louis, Senior Vice President of Research and Development, STEMCELL. “Scientific education – in the classroom and out in the world – can lead to life-changing experiences and limitless opportunities for young women and girls. STEMCELL is proud to support the Girls and STEAM program to make science more accessible, and help ignite the passion of the next generation of scientists and leaders.”

The Girls and STEAM program provides a welcoming space where individuals aged 12-14 who identify as a girl, trans, genderqueer, non-binary, Two-Spirit, and gender-questioning, can participate in STEAM-based learning experiences in person and online, connect with people working in STEAM-related careers, and discover future STEAM opportunities.

"At Science World, we're committed to providing 'Science for All,' and that includes breaking down barriers that keep girls and women from fully participating in STEAM fields," said Tracy Redies, President and CEO, Science World. "It's about providing them with opportunities and fostering a culture of equity in STEAM industries. We're thrilled to create a platform where young women and girls in our community can be inspired by accomplished women with exciting careers in science."

To learn more about Girls and STEAM, please visit the Science World website. More information about STEMCELL’s commitment to diversity and inclusion is available here.

About Science World

Science World is a BC-based charitable organization that engages the people of British Columbia in STEAM literacy. Their mission is to ignite wonder and empower dreams through science and nature. Their vision is that within a generation, Canada will be a country of thriving, sustainable communities rooted in science, innovation and a deep connection to nature.

About STEMCELL Technologies

STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.

Contacts

Media
For more information and to arrange an interview:
Ryan-Sang Lee
Senior Manager, Corporate Communications, STEMCELL Technologies
public.relations@stemcell.com

STEMCELL Technologies



Contacts

Media
For more information and to arrange an interview:
Ryan-Sang Lee
Senior Manager, Corporate Communications, STEMCELL Technologies
public.relations@stemcell.com

Social Media Profiles
More News From STEMCELL Technologies

STEMCELL Launches Novel Cell-Engineering CellPore™ Transfection System

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies has commercially launched the CellPore™ Transfection System, providing a groundbreaking new technology with the potential to advance cell engineering research and the development of novel cell therapies to cure diseases. The CellPore™ Transfection System represents a substantial leap forward for cell engineering researchers, offering a novel method—known as mechanoporation—for cargo delivery into mammalian cells. Unlike traditi...

STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment. The kit can be used to enrich plasma cells expressing the CD138 marker (CD138+ cells) from patient bone marrow samples. Such cell-type-specific enrichmen...

STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders today, marks another significant milestone for STEMCELL, Canada...
Back to Newsroom